COVID-19 in liver transplant recipients
Authors:
- Juliana PiedadeJPJuliana Piedade
- Gustavo PereiraGPGustavo Pereira
Open Access
- 1 July 2021
- journal article
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 3, 100026
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Opportunistic Infections in Transplant PatientsInfectious Disease Clinics of North America, 2019
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective StudyGastroenterology, 2015
- Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant settingJournal of Hepatology, 2013
- RNA Respiratory Viruses in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Serologic Vaccination Response after Solid Organ Transplantation: A Systematic ReviewPLOS ONE, 2013
- Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantationLiver Transplantation, 2012
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000